221 related articles for article (PubMed ID: 20368337)
21. Neutrophil elastase and proteinase-3 trigger G protein-biased signaling through proteinase-activated receptor-1 (PAR1).
Mihara K; Ramachandran R; Renaux B; Saifeddine M; Hollenberg MD
J Biol Chem; 2013 Nov; 288(46):32979-90. PubMed ID: 24052258
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of thrombin bound to the uncleaved extracellular fragment of PAR1.
Gandhi PS; Chen Z; Di Cera E
J Biol Chem; 2010 May; 285(20):15393-15398. PubMed ID: 20236938
[TBL] [Abstract][Full Text] [Related]
23. Interaction of thrombin with PAR1 and PAR4 at the thrombin cleavage site.
Nieman MT; Schmaier AH
Biochemistry; 2007 Jul; 46(29):8603-10. PubMed ID: 17595115
[TBL] [Abstract][Full Text] [Related]
24. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
Hammes SR; Coughlin SR
Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
[TBL] [Abstract][Full Text] [Related]
25. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
[TBL] [Abstract][Full Text] [Related]
26. beta -Arrestins regulate protease-activated receptor-1 desensitization but not internalization or Down-regulation.
Paing MM; Stutts AB; Kohout TA; Lefkowitz RJ; Trejo J
J Biol Chem; 2002 Jan; 277(2):1292-300. PubMed ID: 11694535
[TBL] [Abstract][Full Text] [Related]
27. Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin.
Schuepbach RA; Feistritzer C; Brass LF; Riewald M
Blood; 2008 Mar; 111(5):2667-73. PubMed ID: 18089851
[TBL] [Abstract][Full Text] [Related]
28. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization.
McLaughlin JN; Patterson MM; Malik AB
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5662-7. PubMed ID: 17376866
[TBL] [Abstract][Full Text] [Related]
29. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
[TBL] [Abstract][Full Text] [Related]
30. Phosphoproteomic analysis of protease-activated receptor-1 biased signaling reveals unique modulators of endothelial barrier function.
Lin Y; Wozniak JM; Grimsey NJ; Girada S; Patwardhan A; Molinar-Inglis O; Smith TH; Lapek JD; Gonzalez DJ; Trejo J
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):5039-5048. PubMed ID: 32071217
[TBL] [Abstract][Full Text] [Related]
31. Characterization of thrombin-bound dabigatran effects on protease-activated receptor-1 expression and signaling in vitro.
Chen B; Soto AG; Coronel LJ; Goss A; van Ryn J; Trejo J
Mol Pharmacol; 2015 Jul; 88(1):95-105. PubMed ID: 25934730
[TBL] [Abstract][Full Text] [Related]
32. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling.
Riewald M; Ruf W
J Biol Chem; 2005 May; 280(20):19808-14. PubMed ID: 15769747
[TBL] [Abstract][Full Text] [Related]
33. Distinct roles of protease-activated receptors in signal transduction regulation of endothelial nitric oxide synthase.
Suzuki H; Motley ED; Eguchi K; Hinoki A; Shirai H; Watts V; Stemmle LN; Fields TA; Eguchi S
Hypertension; 2009 Feb; 53(2):182-8. PubMed ID: 19064814
[TBL] [Abstract][Full Text] [Related]
34. PAR1 cleavage and signaling in response to activated protein C and thrombin.
Ludeman MJ; Kataoka H; Srinivasan Y; Esmon NL; Esmon CT; Coughlin SR
J Biol Chem; 2005 Apr; 280(13):13122-8. PubMed ID: 15665002
[TBL] [Abstract][Full Text] [Related]
35. Regulated shedding of PAR1 N-terminal exodomain from endothelial cells.
Ludeman MJ; Zheng YW; Ishii K; Coughlin SR
J Biol Chem; 2004 Apr; 279(18):18592-9. PubMed ID: 14982936
[TBL] [Abstract][Full Text] [Related]
36. Structural basis for thrombin activation of a protease-activated receptor: inhibition of intramolecular liganding.
Seeley S; Covic L; Jacques SL; Sudmeier J; Baleja JD; Kuliopulos A
Chem Biol; 2003 Nov; 10(11):1033-41. PubMed ID: 14652070
[TBL] [Abstract][Full Text] [Related]
37. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin.
Shapiro MJ; Weiss EJ; Faruqi TR; Coughlin SR
J Biol Chem; 2000 Aug; 275(33):25216-21. PubMed ID: 10837487
[TBL] [Abstract][Full Text] [Related]
38. Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion.
Booden MA; Eckert LB; Der CJ; Trejo J
Mol Cell Biol; 2004 Mar; 24(5):1990-9. PubMed ID: 14966279
[TBL] [Abstract][Full Text] [Related]
39. Paradigm of Biased PAR1 (Protease-Activated Receptor-1) Activation and Inhibition in Endothelial Cells Dissected by Phosphoproteomics.
van den Eshof BL; Hoogendijk AJ; Simpson PJ; van Alphen FPJ; Zanivan S; Mertens K; Meijer AB; van den Biggelaar M
Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1891-1902. PubMed ID: 28818855
[TBL] [Abstract][Full Text] [Related]
40. Protease-activated receptor 1 (PAR1) coupling to G(q/11) but not to G(i/o) or G(12/13) is mediated by discrete amino acids within the receptor second intracellular loop.
McCoy KL; Gyoneva S; Vellano CP; Smrcka AV; Traynelis SF; Hepler JR
Cell Signal; 2012 Jun; 24(6):1351-60. PubMed ID: 22306780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
